SmaRTWork - a Decision Support System to Promote Return to Work Among People Sick-listed With Musculoskeletal Disorders
SmaRTWork
2 other identifiers
interventional
298
1 country
1
Brief Summary
The objective of this study is to evaluate the effect of an intervention, SmaRTWork, on return to work compared to usual care for individuals who are sick-listed due to musculoskeletal disorders. Potential participants are individuals of working age (20-59 years) sick-listed due to a musculoskeletal disorder (neck pain, low back pain, or widespread pain) for up to 12 weeks living in Norway. The primary outcome will be time to sustainable return to work. We will also evaluate the effect on other work outcomes and health outcomes. We will also interview participants and stakeholders about their experience with the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
January 15, 2026
January 1, 2026
2.8 years
June 13, 2025
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to sustainable return-to-work (RTW)
Time to sustainable return-to-work (RTW), i.e., one month without receiving sickness benefits, during the 12 months of follow-up from randomization based on registry data
12 months from randomization
Secondary Outcomes (11)
Number of sickness absence days
12 months from randomization
Probability of working each month
12 months from randomization
Musculoskeletal Health Questionnaire (MSK-HQ)
From randomization to 12 months of follow-up
Health-related quality of life
12 months from randomization
Average pain last week
12 months from randomization
- +6 more secondary outcomes
Study Arms (2)
SmaRTWork
EXPERIMENTALThis group receives the SmaRTWork intervention in addition to usual care
Usual care
NO INTERVENTIONThe participants receive usual care as if they were not part of any study. There are no restrictions on what they can or cannot do.
Interventions
The SmaRTWork app provides weekly individually tailored self-management plans by matching the participant's health information and sick leave status with targeted educational messages, physical activity advice, and exercise recommendations. In addition, participants with specific problems regarding i) work accommodations, ii) workplace conflicts, iii) large responsibilities as caregivers, iv) financial problems, or v) who do not think they will return to the old workplace are offered to be set in contact with a caseworker at the social insurance office. The intervention is given in addition to usual care.
Eligibility Criteria
You may qualify if:
- Individuals 20-59 years old (working age)
- Living in Norway
- Sick-listed due to a musculoskeletal disorder for up to 12 weeks
- Musculoskeletal complaints are the main reason for sick leave.
- The main diagnosis for sick leave is unspecific pain, for example one of the following (ICPC-2 diagnoses codes):
- Neck symptom/complaint (L01)
- Back symptom/complaint (L02)
- Low back symptom/complaint (L03)
- Muscle pain (L18)
- Back syndrome without radiating pain (L84)
You may not qualify if:
- Do not have a smartphone with internet access (i.e., to be able to download and access the SmaRTWork app).
- Pregnant
- No employer (unemployed or self-employed)
- Poor Norwegian comprehension
- Sick listed for more than 3 months the last year
- Have a planned date for RTW during the next week
- Have previously participated in the study or currently participating in other studies
- Unable to take part in exercise/physical activity (e.g., use of walking aids, unable to get up and down on the floor independently)
- Leg pain worse than back pain
- Red flags that could indicate serious underlying pathology:
- Changes in bladder or bowel function
- General feeling of being unwell (malaise), fever and/or unexplained weight loss
- Reduced muscle (motor) function, sensory loss, walking problems or balance problems
- Neck or back pain that started after the age of 55 or feel different from previous pain episodes
- Pain that does not improve with rest or light activity or pain that is much worse during the night
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norwegian University of Science and Technology
Trondheim, 7027, Norway
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Lene Aasdahl, MD PhD
Norwegian University of Science and Technology
- STUDY CHAIR
Solveig K Grudt, Head of Department
Norwegian University of Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 24, 2025
Study Start
March 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Due to the ethical consent data cannot be shared.